|
1
|
Aljiffry M, Abdulelah A, Walsh M,
Peltekian K, Alwayn I and Molinari M: Evidence-based approach to
cholangiocarcinoma: A systematic review of the current literature.
J Am Coll Surg. 208:134–147. 2009. View Article : Google Scholar
|
|
2
|
Shaib YH, Davila JA, McGlynn K and
El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in
the United States: A true increase? J Hepatol. 40:472–477. 2004.
View Article : Google Scholar
|
|
3
|
Florio AA, Ferlay J, Znaor A, Ruggieri D,
Alvarez CS, Laversanne M, Bray F, McGlynn KA and Petrick JL: Global
trends in intrahepatic and extrahepatic cholangiocarcinoma
incidence from 1993 to 2012. Cancer. 126:2666–2678. 2020.
View Article : Google Scholar
|
|
4
|
Bertuccio P, Malvezzi M, Carioli G, Hashim
D, Boffetta P, El-Serag HB, La Vecchia C and Negri E: Global trends
in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
J Hepatol. 71:104–114. 2019. View Article : Google Scholar
|
|
5
|
Roayaie S, Guarrera JV, Ye MQ, Thung SN,
Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM and Schwartz ME:
Aggressive surgical treatment of intrahepatic cholangiocarcinoma:
Predictors of outcomes. J Am Coll Surg. 187:365–372. 1998.
View Article : Google Scholar
|
|
6
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008. View Article : Google Scholar
|
|
7
|
Massani M, Nistri C, Ruffolo C, Bonariol
R, Pauletti B, Bonariol L, Caratozzolo E, Morana G and Bassi N:
Intrahepatic chemotherapy for unresectable cholangiocarcinoma:
Review of literature and personal experience. Updates Surg.
67:389–400. 2015. View Article : Google Scholar
|
|
8
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar
|
|
9
|
Ho CT, Shang HS, Chang JB, Liu JJ and Liu
TZ: Folate deficiency-triggered redox pathways confer drug
resistance in hepatocellular carcinoma. Oncotarget. 6:26104–26118.
2015. View Article : Google Scholar
|
|
10
|
Zhao LJ, Xu H, Qu JW, Zhao WZ, Zhao YB and
Wang JH: Modulation of drug resistance in ovarian cancer cells by
inhibition of protein kinase C-alpha (PKC-α) with small
interference RNA (siRNA) agents. Asian Pac J Cancer Prev.
13:3631–3636. 2012. View Article : Google Scholar
|
|
11
|
Balko JM, Cook RS, Vaught DB, Kuba MG,
Miller TW, Bhola NE, Sanders ME, Granja-Ingram NM, Smith JJ,
Meszoely IM, et al: Profiling of residual breast cancers after
neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism
of drug resistance. Nat Med. 18:1052–1059. 2012. View Article : Google Scholar
|
|
12
|
Jia Q, Dong Q and Qin L: CCN: Core
regulatory proteins in the microenvironment that affect the
metastasis of hepatocellular carcinoma? Oncotarget. 7:1203–1214.
2016. View Article : Google Scholar
|
|
13
|
Wu SD, Ma YS, Fang Y, Liu LL, Fu D and
Shen XZ: Role of the microenvironment in hepatocellular carcinoma
development and progression. Cancer Treat Rev. 38:218–225. 2012.
View Article : Google Scholar
|
|
14
|
Hinshaw DC and Shevde LA: The tumor
microenvironment innately modulates cancer progression. Cancer Res.
79:4557–4566. 2019. View Article : Google Scholar
|
|
15
|
Uchibori R, Tsukahara T, Mizuguchi H, Saga
Y, Urabe M, Mizukami H, Kume A and Ozawa K: NF-κB activity
regulates mesenchymal stem cell accumulation at tumor sites. Cancer
Res. 73:364–372. 2013. View Article : Google Scholar
|
|
16
|
Ljujic B, Milovanovic M, Volarevic V,
Murray B, Bugarski D, Przyborski S, Arsenijevic N, Lukic ML and
Stojkovic M: Human mesenchymal stem cells creating an
immunosuppressive environment and promote breast cancer in mice.
Sci Rep. 3:22982013. View Article : Google Scholar
|
|
17
|
Kim JA, Shim JS, Lee GY, Yim HW, Kim TM,
Kim M, Leem SH, Lee JW, Min CK and Oh IH: Microenvironmental
remodeling as a parameter and prognostic factor of heterogeneous
leukemogenesis in acute myelogenous leukemia. Cancer Res.
75:2222–2231. 2015. View Article : Google Scholar
|
|
18
|
He W, Liang B, Wang C, Li S, Zhao Y, Huang
Q, Liu Z, Yao Z, Wu Q, Liao W, et al: MSC-regulated lncRNA
MACC1-AS1 promotes stemness and chemoresistance through fatty acid
oxidation in gastric cancer. Oncogene. 38:4637–4654. 2019.
View Article : Google Scholar
|
|
19
|
Gu ZW, He YF, Wang WJ, Tian Q and Di W:
miR-1180 from bone marrow-derived mesenchymal stem cells induces
glycolysis and chemoresistance in ovarian cancer cells by
upregulating the Wnt signaling pathway. J Zhejiang Univ Sci B.
20:219–237. 2019. View Article : Google Scholar
|
|
20
|
Han Z, Jing Y, Xia Y, Zhang S, Hou J, Meng
Y, Yu F, Liu X, Wu M, Zhang P, et al: Mesenchymal stem cells
contribute to the chemoresistance of hepatocellular carcinoma cells
in inflammatory environment by inducing autophagy. Cell Biosci.
4:222014. View Article : Google Scholar
|
|
21
|
Haga H, Yan IK, Takahashi K, Wood J,
Zubair A and Patel T: Tumour cell-derived extracellular vesicles
interact with mesenchymal stem cells to modulate the
microenvironment and enhance cholangiocarcinoma growth. J Extracell
Vesicles. 4:249002015. View Article : Google Scholar
|
|
22
|
Liu J, Han G, Liu H and Qin C: Suppression
of cholangiocarcinoma cell growth by human umbilical cord
mesenchymal stem cells: A possible role of Wnt and Akt signaling.
PLoS One. 8:e628442013. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Konno R, Yamakawa H, Utsunomiya H, Ito K,
Sato S and Yajima A: Expression of survivin and Bcl-2 in the normal
human endometrium. Mol Hum Reprod. 6:529–534. 2000. View Article : Google Scholar
|
|
25
|
Gang EJ, Bosnakovski D, Figueiredo CA,
Visser JW and Perlingeiro RC: SSEA-4 identifies mesenchymal stem
cells from bone marrow. Blood. 109:1743–1751. 2007. View Article : Google Scholar
|
|
26
|
Rasini V, Dominici M, Kluba T, Siegel G,
Lusenti G, Northoff H, Horwitz EM and Schäfer R: Mesenchymal
stromal/stem cells markers in the human bone marrow. Cytotherapy.
15:292–306. 2013. View Article : Google Scholar
|
|
27
|
Tang Q, Wang Q, Zhang Q, Lin SY, Zhu Y,
Yang X and Guo AY: Gene expression, regulation of DEN and HBx
induced HCC mice models and comparisons of tumor, para-tumor and
normal tissues. BMC Cancer. 17:8622017. View Article : Google Scholar
|
|
28
|
Critelli R, Milosa F, Faillaci F, Condello
R, Turola E, Marzi L, Lei B, Dituri F, Andreani S, Sighinolfi P, et
al: Microenvironment inflammatory infiltrate drives growth speed
and outcome of hepatocellular carcinoma: A prospective clinical
study. Cell Death Dis. 8:e30172017. View Article : Google Scholar
|
|
29
|
Alshareeda AT, Sakaguchi K, Abumaree M,
Mohd Zin NK, Shimizu T and Zoran IJPO: The potential of cell sheet
technique on the development of hepatocellular carcinoma in rat
models. PLoS One. 12:e01840042017. View Article : Google Scholar
|
|
30
|
Jiang S, Chang H, Deng S and Fan D:
Icariin enhances the chemosensitivity of cisplatin resistant
ovarian cancer cells by suppressing autophagy via activation of the
AKT/mTOR/ATG5 pathway. Int J Oncol. 54:1933–1942. 2019.
|
|
31
|
Huang S, Qi P, Zhang T, Li F and He X: The
HIF- 1α/miR-224-3p/ATG5 axis affects cell mobility and
chemosensitivity by regulating hypoxia induced protective autophagy
in glioblastoma and astrocytoma. Oncol Rep. 41:1759–1768. 2019.
|
|
32
|
White E, Mehnert JM and Chan CS:
Autophagy, Metabolism, and Cancer. Clin Cancer Res. 21:5037–5046.
2015. View Article : Google Scholar
|
|
33
|
He J, Ding J, Lai Q, Wang X, Li A and Liu
S: Irbesartan ameliorates lipid deposition by enhancing autophagy
via PKC/AMPK/ULK1 axis in free fatty acid induced hepatocytes.
Front Physiol. 10:6812019. View Article : Google Scholar
|
|
34
|
Chen X, Li C, Chen Y, Ni C, Chen X, Zhang
L, Xu X, Chen M, Ma X, Zhan H, et al: Aflatoxin B1 impairs leydig
cells through inhibiting AMPK/mTOR-mediated autophagy flux pathway.
Chemosphere. 233:261–272. 2019. View Article : Google Scholar
|
|
35
|
Zhang J, Yuan B, Zhang H and Li H: Human
epithelial ovarian cancer cells expressing CD105, CD44 and CD106
surface markers exhibit increased invasive capacity and drug
resistance. Oncol Lett. 17:5351–5360. 2019.
|
|
36
|
Nicola AV, Ponce de Leon M, Xu R, Hou W,
Whitbeck JC, Krummenacher C, Montgomery RI, Spear PG, Eisenberg RJ
and Cohen GH: Monoclonal antibodies to distinct sites on herpes
simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J
Virol. 72:3595–3601. 1998. View Article : Google Scholar
|
|
37
|
Wahl C, Wegenka UM, Leithäuser F,
Schirmbeck R and Reimann J: IL-22-dependent attenuation of T
cell-dependent (ConA) hepatitis in herpes virus entry mediator
deficiency. J Immunol. 182:4521–4528. 2009. View Article : Google Scholar
|
|
38
|
Xu H, Cao D, Guo G, Ruan Z, Wu Y and Chen
Y: The intrahepatic expression and distribution of BTLA and its
ligand HVEM in patients with HBV-related acute-on-chronic liver
failure. Diagn Pathol. 7:1422012. View Article : Google Scholar
|
|
39
|
Yu P and Fu YX: Targeting tumors with
LIGHT to generate metastasis-clearing immunity. Cytokine Growth
Factor Rev. 19:285–294. 2008. View Article : Google Scholar
|
|
40
|
Klionsky DJ and Ohsumi Y: Vacuolar import
of proteins and organelles from the cytoplasm. Annu Rev Cell Dev
Biol. 15:1–32. 1999. View Article : Google Scholar
|
|
41
|
Isomoto H, Mott JL, Kobayashi S, Werneburg
NW, Bronk SF, Haan S and Gores GJ: Sustained IL-6/STAT-3 signaling
in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Gastroenterology. 132:384–396. 2007. View Article : Google Scholar
|
|
42
|
Meng F, Yamagiwa Y, Ueno Y and Patel T:
Over-expression of interleukin-6 enhances cell survival and
transformed cell growth in human malignant cholangiocytes. J
Hepatol. 44:1055–1065. 2006. View Article : Google Scholar
|
|
43
|
Asukai K, Kawamoto K, Eguchi H, Konno M,
Nishida N, Koseki J, Noguchi K, Hasegawa S, Ogawa H, Yamada D, et
al: Prognostic impact of peritumoral IL-17-positive cells and IL-17
axis in patients with intrahepatic cholangiocarcinoma. Ann Surg
Oncol. 22 (Suppl 3):S1524–S1531. 2015. View Article : Google Scholar
|
|
44
|
Burman C and Ktistakis NT: Autophagosome
formation in mammalian cells. Semin Immunopathol. 32:397–413. 2010.
View Article : Google Scholar
|
|
45
|
Komatsu M and Ichimura Y: Selective
autophagy regulates various cellular functions. Genes Cells.
15:923–933. 2010. View Article : Google Scholar
|
|
46
|
Pei X, Li Y, Zhu L and Zhou Z:
Astrocyte-derived exosomes suppress autophagy and ameliorate
neuronal damage in experimental ischemic stroke. Exp Cell Res.
382:1114742019. View Article : Google Scholar
|
|
47
|
Shi W, Ma H, Liu T, Yan D, Luo P, Zhai M,
Tao J, Huo S, Guo J, Li C, et al: Inhibition of
Interleukin-6/glycoprotein 130 signalling by Bazedoxifene
ameliorates cardiac remodelling in pressure overload mice. J Cell
Mol Med. 24:4748–4761. 2020. View Article : Google Scholar
|
|
48
|
Lu H, Han M, Yuan X, Tursun K, Zhang Y, Li
Y, Li Z, Feng S, Zhou L, Pan Z, et al: Role of IL-6-mediated
expression of NS5ATP9 in autophagy of liver cancer cells. J Cell
Physiol. 233:9312–9319. 2018. View Article : Google Scholar
|
